Stada Arzneimittel AG operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Stada Arzneimittel AG with three other
pharmaceutical manufacturers in Europe:
sales of 2.01 billion Euro [US$2.49 billion]
of which 79%
was Specialty Care),
Hikma Pharmaceuticals PLC
of the United Kingdom
(£1.49 billion [US$2.11 billion]
of which 40%
was Injectable Pharmaceuticals), and
H. Lundbeck A/S
based in Denmark
(17.23 billion Danish Kroner [US$2.86 billion]
of which 18%
Stada Arzneimittel AG reported sales of 2.31 billion Euro (US$2.86 billion)
December of 2017.
increase of 8.2%
versus 2016, when the company's sales were 2.14 billion Euro.
Sales at Stada Arzneimittel AG have increased during each of the previous five years
(and since 2012, sales have increased a total of 26%).
Sales of Branded Products saw an increase
10.9% in 2017, from
858.46 million Euro to 952.25 million Euro.